Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 20 | 0 | 262 | 3,002 | 1,350 |
| Gross Profit | 20 | N/A | 262 | 3,002 | 1,350 |
| Operating Expenses | 98,822 | 87,823 | 104,975 | 96,875 | 80,685 |
| Operating Income | -98,802 | -87,823 | -104,713 | -93,873 | -79,335 |
| Interest Expense | 1,120 | 1,144 | 1,163 | 1,125 | 1,203 |
| Other Income | 2,484 | 4,039 | 5,669 | 6,687 | 7,673 |
| Pre-tax Income | -97,438 | -84,928 | -100,207 | -88,311 | -72,865 |
| Net Income Continuous | -97,438 | -84,928 | -100,207 | -88,311 | -72,865 |
| Net Income | $-97,438 | $-84,928 | $-100,207 | $-88,311 | $-72,865 |
| EPS Basic Total Ops | -1.69 | -1.61 | -2.00 | -1.84 | -1.46 |
| EPS Basic Continuous Ops | -1.69 | -1.61 | -2.00 | -1.85 | -1.46 |
| EPS Diluted Total Ops | -1.69 | -1.61 | -2.00 | -1.71 | -1.46 |
| EPS Diluted Continuous Ops | -1.69 | -1.61 | -2.00 | -1.71 | -1.46 |
| EPS Diluted Before Non-Recurring Items | -1.69 | -1.61 | -2.00 | N/A | N/A |
| EBITDA(a) | $-97,107 | $-86,889 | $-104,027 | $-93,684 | $-80,091 |